New patent expiration for Viiv Hlthcare drug SELZENTRY

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SELZENTRY
Annual Drug Patent Expirations for SELZENTRY

Selzentry is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

SELZENTRY drug price trends.

The generic ingredient in SELZENTRY is maraviroc. One supplier is listed for this compound. Additional details are available on the maraviroc profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top